Navigation Links
New Stroke Treatments Reduce Brain Damage, Improve Recovery
Date:2/21/2008

Caffeine-alcohol mix plus clot-busting drug proves potent resource as does body cooling with fever reducer

THURSDAY, Feb. 21 (HealthDay News) -- Giving stroke patients a caffeine-alcohol mixture in concert with a clot-busting drug was safe and led to better recovery, new research shows.

One of the researchers has a patent on the mixture, called caffeinol, but lead author Dr. Sheryl Martin-Schild, a neurovascular fellow at the University of Texas Health Science Center, noted that, "this could easily be put together by pharmacists, it's easy to deliver and well-tolerated."

The group has U.S. Food and Drug Administration approval to use caffeinol in studies and is hoping approval for "common consumption" will follow.

This was one of several studies on new stroke treatments that were detailed during a teleconference Thursday as part of the American Stroke Associations International Stroke Conference in New Orleans.

Previous studies showed that caffeinol, a combination of caffeine and ethanol that is the equivalent of four to six cups of strong coffee and a shot of alcohol, reduced brain damage and improved recovery when used in mice.

"When this medication was given, the final size of the stroke was much smaller than if the animal did not get caffeinol," Martin-Schild said. The combination also lowered body temperature, which further limited damage and enhanced recovery.

In the Phase I study presented Thursday, 10 adult stroke patients received the clot-busting drug tPA within three hours and an infusion of caffeinol within six hours of the stroke, while 90 received tPA alone within three hours of the beginning of stroke symptoms.

By the time they were discharged from the hospital, 60 percent of those in the caffeinol group had little or no disability, compared with 26 percent of those who had received tPA alone.

Although the severity of stroke was worse at baseline in those who received caffeinol and tPA, those patients actually did better, Martin-Schild said.

The researchers are now moving to randomized trials.

A second study found that cooling stroke patients with a fever-reducing drug and ice helps reduce both fever and the collection of fluid around the brain. This would be an alternative to moderate hypothermia (body cooling), which requires general anesthesia.

Of the 20 patients studied, the body-cooling therapy showed reduced brain damage when compared with the hospital records of 60 similar patients who did not receive hypothermia, according to the authors, from the National Cardiovascular Center in Suita, Japan.

Yet another study, this one from Spain, found that a modified form of tPA, called tenecteplase, was better at re-opening blocked brain arteries than standard tPA. Tenecteplase stays in the blood longer and is drawn more to fibrin, a protein associated with clotting.

Although the time it took to begin re-opening the artery was similar in both groups (27 to 35 minutes), the tenecteplase patients had experienced more progress two hours after the procedure, with an average of 69 percent of the artery cleared compared with only 53 percent in those treated with tPA. Just over 42 percent of the tenecteplase patients saw complete re-opening of the artery versus 33.4 percent of tPA patients.

A final study, from researchers in South Korea, found that stem cells from human fat tissue might one day be able to treat ischemic strokes. Rats who received transplantations of these cells showed better brain blood flow and other signs of improved stroke recovery.

More information

The American Stroke Association has more on ischemic stroke.



SOURCES: Sheryl Martin-Schild, M.D., Ph.D., University of Texas Health Science Center, Houston; Feb. 21, 2008, presentations, American Stroke Association's International Stroke Conference, New Orleans


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Mammograms Might Spot Stroke Risk
2. In-Hospital Stroke Deaths Rise on Nights, Weekends
3. Music Therapy Improves Stroke Outcomes
4. Middle-Aged Women Gaining Weight, Raising Their Stroke Risk
5. Logistical information for the 2008 International Stroke Conference
6. Stem Cells Repair Stroke Damage in Rats
7. ASA International Stroke Conference 2008
8. Human stem cells aid stroke recovery in rats
9. Physicians Still Hopeful About Desmoteplase for the Treatment of Acute Ischemic Stroke Despite Negative Results
10. Stem cell therapy studies for stroke, cerebral palsy prepare for clinical trials
11. Concentric Medical Announces European Release of Expanded Family of Neurovascular Retrievers for use in Stroke Patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Stroke Treatments Reduce Brain Damage, Improve Recovery 
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: